We are live on ! Find out more
SGK

Steigerwald Gordon & Koch Portfolio holdings

AUM $1.01B
1-Year Est. Return 15.33%
This Fund
S&P 500
This Quarter Est. Return
+6.46%
1 Year Est. Return
+15.33%
3 Year Est. Return
+59.48%
5 Year Est. Return
+77.26%
10 Year Est. Return
+288.1%
AUM
$314M
AUM Growth
+$26.3M
Cap. Flow
+$9.97M
Cap. Flow %
3.18%
Top 10 Hldgs %
30.3%
Holding
88
New
17
Increased
41
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$2.84M
2
AAPL icon
Apple
AAPL
+$556K
3
SYK icon
Stryker
SYK
+$504K
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$464K
5
AMGN icon
Amgen
AMGN
+$419K

Sector Composition

Rank Sector Weight
1 Technology 24.58%
2 Healthcare 16.48%
3 Communication Services 11.71%
4 Energy 9.42%
5 Financials 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GD icon
76
General Dynamics
GD
$105B
$220K 0.07%
+1,273
New +$208K
PM icon
77
Philip Morris
PM
$301B
$213K 0.07%
+2,326
New +$216K
WBA
78
DELISTED
Walgreens Boots Alliance
WBA
$211K 0.07%
2,555
TGT icon
79
Target
TGT
$62.1B
$206K 0.07%
+2,857
New +$207K
LMT icon
80
Lockheed Martin
LMT
$134B
$205K 0.07%
+819
New +$205K
V icon
81
Visa
V
$677B
$200K 0.06%
+2,559
New +$206K
EOI
82
Eaton Vance Enhanced Equity Income Fund
EOI
$808M
$186K 0.06%
15,000
MSP
83
DELISTED
Madison Strategic Sector
MSP
$178K 0.06%
15,000
EOS
84
Eaton Vance Enhance Equity Income Fund II
EOS
$1.14B
$128K 0.04%
10,000
OPK icon
85
Opko Health
OPK
$921M
$109K 0.03%
11,700
-4,800
-29% -$49.7K
BUD icon
86
AB InBev
BUD
$158B
-2,920
Closed -$384K
EFA icon
87
iShares MSCI EAFE ETF
EFA
$76.4B
-3,495
Closed -$207K
LGND icon
88
Ligand Pharmaceuticals
LGND
$6.02B
-3,203
Closed -$204K

Similar funds

Steigerwald Gordon & Koch's Q4 2016 Portfolio in Review

As of Q4 2016, Steigerwald Gordon & Koch held 88 positions worth $314M, up 9.1% from $287M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Steigerwald Gordon & Koch deployed $9.97M of net new capital in Q4 2016, opening 17 new positions and adding to 41 existing holdings. Its largest new stake was CDK Global, Inc.: 49,576 shares worth $2.92M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was NextGen Healthcare, Inc. Common Stock, an estimated $1.23M trimmed.

  • Steigerwald Gordon & Koch's largest Q4 2016 buy was CDK Global, Inc.: 49,576 shares worth $2.92M.
  • Steigerwald Gordon & Koch added most to Apple in Q4 2016, an estimated $556K increase.
  • Steigerwald Gordon & Koch's biggest Q4 2016 reduction was NextGen Healthcare, Inc. Common Stock, cutting an estimated $1.23M.
  • Steigerwald Gordon & Koch fully exited AB InBev in Q4 2016, selling an estimated $384K.
  • Steigerwald Gordon & Koch's ten largest holdings make up 30% of its $314M portfolio in Q4 2016.
  • Steigerwald Gordon & Koch opened 17 new positions and closed 3 in Q4 2016.
  • Steigerwald Gordon & Koch's portfolio value rose 9.1% quarter-over-quarter to $314M.

Based on Steigerwald Gordon & Koch's 13F filing for Q4 2016, filed 13 Sep 2018.